Indranil Dey
Algemeen Directeur bij BLUEJAY DIAGNOSTICS, INC.
Vermogen: 123 539 $ op 31-05-2024
Profiel
Indranil Dey is the founder of Bluejay Diagnostics, Inc. (founded in 2015) and Lana Management & Business Research International LLC (founded in 2007).
At Bluejay Diagnostics, Inc., he holds the titles of President, CEO, CFO, CAO & Director.
At Lana Management & Business Research International LLC, he held the title of Chief Operating Officer from 2008 to 2015.
Dr. Dey also has former job experience.
He worked as a Manager-Technology Licensing at Ciba-Geigy Corp.
and Thomas Jefferson University.
At IMPATH, Inc., he served as the Head-Western US Business Development from 2001 to 2005.
He was the Vice President-Business Development & Market at Definiens AG from 2005 to 2007.
Additionally, he worked as the Chief Business Officer at Genmethrax, Inc. In terms of education, Dr. Dey holds an MBA from the University of Cambridge.
He also completed his undergraduate and graduate degrees at Visva-Bharati University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-12-2023 | 233 093 ( 8.03% ) | 123 539 $ | 31-05-2024 |
Actieve functies van Indranil Dey
| Bedrijven | Functie | Begin |
|---|---|---|
| BLUEJAY DIAGNOSTICS, INC. | Algemeen Directeur | 01-01-2015 |
Eerdere bekende functies van Indranil Dey
| Bedrijven | Functie | Einde |
|---|---|---|
| Lana Management & Business Research International LLC | Oprichter | 01-01-2015 |
Definiens AG
 Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Corporate Officer/Principal | 01-01-2007 |
| IMPATH, Inc. | Corporate Officer/Principal | 01-01-2005 |
| Genmethrax, Inc. | Corporate Officer/Principal | - |
| Ciba-Geigy Corp. | Corporate Officer/Principal | - |
Opleiding van Indranil Dey
| University of Cambridge | Masters Business Admin |
| Visva-Bharati University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BLUEJAY DIAGNOSTICS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
| Ciba-Geigy Corp. | Health Technology |
| IMPATH, Inc. | Health Services |
Definiens AG
Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Technology Services |
| Lana Management & Business Research International LLC | |
| Genmethrax, Inc. |
